PRECISION BIOSCIENCES INC (DTIL) › Cash & EquivalentsPRECISION BIOSCIENCES INC (DTIL) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2018: $103.19M2019: $180.89M2020: $89.80M2021: $143.66M2022: $189.58M2023: $116.68M2024: $85.90M2025: $110.82M$110.82M2018Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$110.82M+29.0%2024$85.90M-26.4%2023$116.68M-38.5%2022$189.58M+32.0%2021$143.66M+60.0%2020$89.80M-50.4%2019$180.89M+75.3%2018$103.19M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share